glp-1 drugs approved for weight loss Comparing Ozempic, Wegovy and Other The U.S. Food and Drug
Description
GLP-1 provides the strong appetite suppression that makes eating less feasible and sustainable
With findings from numerous trials on glycemic, body weight and CV outcomes scheduled to be presented over the next 4 years, many more treatment options could be become available for providers in the near future, Davies said
10.1186/s12885-023-11077-w 62 MadsenM
WHO in September added GLP-1 drugs as a diabetes treatment to its list of essential medicines, but stopped short of adding them for obesity alone
Trulicity: Summary of product characteristics
